Approvals/TGA/Bivalirudin ARX bivalirudin (as trifluoroacetate) 250mg powder for injection vial

Approved

STANDARD

Bivalirudin ARX bivalirudin (as trifluoroacetate) 250mg powder for injection vial

Arrotex Pharmaceuticals Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 7f1cfba9d5646961
Product Name: Bivalirudin ARX bivalirudin (as trifluoroacetate) 250mg powder for injection vial
Artg Id: 241714
Artg Name: Bivalirudin ARX bivalirudin (as trifluoroacetate) 250mg powder for injection vial
Sponsor: Arrotex Pharmaceuticals Pty Ltd
Company Detail Path: /organization/arrotex-pharmaceuticals-pty-ltd
Artg Date: 2016-05-17
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/39987ca18efdbabef0c9f0c72799999f.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/b2ade0d92435192c5aefdac32066014f.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

7f1cfba9d5646961

Type

Standard